Application of the improved abdominal rotation card method in insulin injection
10.3760/cma.j.issn.1672-7088.2016.22.006
- VernacularTitle:改良腹部注射部位轮换卡在胰岛素注射中的应用效果
- Author:
Wei YIN
;
Shan FAN
;
Zhijuan LI
;
Hongmei GUO
;
Hongbing BU
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus;
Insulin;
Hypodermic injection;
The new abdominal rotation method in insulin injection
- From:
Chinese Journal of Practical Nursing
2016;32(22):1706-1709
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of the improved abdominal rotation card method in insulin injection. Methods A total of 100 hospitalized diabetes patients were randomly divided into control group (n=50) and observational group (n=50) according to the random number method. In the control group, insulin was injected to the subcutaneous tissue of abdomen with traditional method annular rotating method. Insulin was injected using improved abdominal rotation card method in the observational group. Compare accuracy and mastery rate of injection site rotation between the two groups. Compare fasting blood glucose (FBG), postprandial 2H blood glucose (PBG), HbA1c, the incidence of hypoglycemia and endermic induration between the two groups after three months. Results The nurses in the observation group had higher accuracy rate of the injection site rotation compared to the control group [98.6%(690/700) vs. 38.6%(270/700),χ2=584.66, P<0.01]. Mastery rate of the injection site rotation for the patients in the observation group were significantly higher than the control group [70.0% (35/50) vs. 20.0% (10/50), χ2=25.74, P < 0.01]. The incidence of endermic induration were significantly lower in observation group compared to the control group [2.0% (1/50) vs.16.0% (8/50), χ2=5.98, P < 0.01]. The incidence of hypoglycemia were significantly lower in observation group compared to the control group [4.0%(2/50) vs. 16.0%(8/50),χ2=4.00, P<0.01]. Conclusions The new abdominal rotation method in insulin injection can be a safe and effective therapy in patients with type 2 diabetes.
